v3.25.2
Condensed Consolidated Balance Sheets
$ in Millions
Jun. 27, 2025
USD ($)
$ / shares
shares
Dec. 27, 2024
USD ($)
$ / shares
shares
Cash and cash equivalents $ 497.8 $ 382.6
Accounts receivable, less allowance for doubtful accounts of $3.3 million and $6.2 million 410.7 395.3
Inventories 594.0 664.9
Prepaid expenses and other current assets 112.7 186.3
Total current assets 1,615.2 1,629.1
Property, plant and equipment, net 414.3 390.6
Intangible assets, net 393.1 419.4
Other assets 205.4 211.7
Total Assets 3,286.3 3,302.6
Current maturities of long-term debt 3.9 3.9
Accounts payable 78.4 57.8
Accrued payroll and payroll-related costs 76.3 108.1
Accrued interest 13.7 9.2
Medicaid lawsuit liability 33.7 21.3
Accrued and other current liabilities 250.6 231.1
Total current liabilities 456.6 431.4
Long-term debt 901.4 909.5
Acthar Gel-Related Settlement, Non-current 102.7 126.5
Pension and postretirement benefits 27.1 26.5
Environmental liabilities 34.0 34.3
Other income tax liabilities 24.8 25.7
Other liabilities 97.8 102.9
Other liabilities 1,644.4 1,656.8
Ordinary A shares 0.0 0.0
Ordinary shares 0.2 0.2
Deferred Tax Assets, Net $ 658.3 $ 651.8
Ordinary shares, shares issued (in shares) | shares 19,762,306 19,696,335
Ordinary shares, shares authorized (in shares) | shares 500,000,000 500,000,000
Common Stock, Shares, Outstanding | shares 19,736,759 19,696,335
Ordinary shares, par value (in usd per share) | $ / shares $ 0.01 $ 0.01
Ordinary shares held in treasury at cost $ (1.9) $ 0.0
Additional Paid in Capital 1,214.4 1,199.8
Accumulated Other Comprehensive Income (Loss), Net of Tax 13.9 6.1
Retained earnings 415.3 439.7
Total Shareholders' Equity 1,641.9 1,645.8
Total Liabilities and Shareholders' Equity $ 3,286.3 $ 3,302.6
Ordinary A    
Ordinary shares, shares authorized (in shares) | shares 25,000 25,000
Common Stock, Shares, Outstanding | shares 0 0